content top

Intravitreal Bevacizumab in Nanophthalmic Exudative Retinal Detachment

Satyen Deka, H Bhattacharjee, H Deka, M J Barman, S M Das (Guwahati, India) Advantages: Currently the only treatment option for exudative RD in nanophthalmic eye is surgical (Scleral Resection) with guarded visual prognosis. Intravitreal bevacizumab is a less invasive and safe treatment used for multiple retinal vascular/inflammatory diseases to treat the macular edema, the mode of action of which is through blockage of VEGF mediated...

Read More

Preoperative Intravitreal Bevacizumab in Diabetic Tractional Retinal Detachment

Satyen Deka, H Bhattacharjee, H Deka, M J Barman, R Saibum, S M Das (Guwahati, India) Advantages: Preoperative intravitreal bevacizumab in diabetic tractional retinal detachment (TRD) facilitates surgery, decreases the intraoperative bleeding and improves the visual acuity. Methods: In this non comparative interventional case series 10 eyes of 8 candidate diabetic TRD patients received 1.25 mg intravitreal off level bevacizumab 2-7 days...

Read More
content top